AstraZeneca's Tudorza Pressair successful in Phase 4 COPD study [Seeking Alpha]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Seeking Alpha
AstraZeneca's Tudorza Pressair successful in Phase 4 COPD studyResults from the Phase 4 ASCENT study showed AstraZeneca's (NYSE:AZN)Tudorza Pressair (aclidinium bromide) 400 µg, administered twice daily as background therapy, produced a statistically significant reduction on the annual rate of moderate or severe exacerbations compared to placebo in patients with moderate-to-very severe chronic obstructive pulmonary disease (COPD) with significant cardiovascular risk factors.The study also met the primary safety endpoint.The company is continuing its analysis of the data. Complete results will be shared with the FDA and submitted for presentation at a future medical conference. It also plans to file a U.S. marketing application for the expanded indication of Tudorza.AstraZeneca is collaborating with Circassia Pharmaceuticals on the development and commercialization of Tudorza and Duaklir (aclidinium bromide/formoterol) in the U.S.Now read:Week In Review: Walgreens Boots Alliance Spends
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Four ways the vaccine rush will define infectious disease trends for CROs in 2024 [Yahoo! Finance]Yahoo! Finance
- Helping save lives: 2,300 teachers received the Opioid Overdose Response Training to teach high school students how to react when facing a suspected opioid overdose [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Helping save lives: 2,300 teachers received the Opioid Overdose Response Training to teach high school students how to react when facing a suspected opioid overdose [Yahoo! Finance]Yahoo! Finance
- AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles [Fortune]Fortune
- Bigger Cambridge Biomedical Campus "priority" - Gove [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 5/7/24 - Form 6-K
- 5/2/24 - Form 6-K
- 5/1/24 - Form 6-K
- AZN's page on the SEC website